ASPEYA
LIVE

Serial Number

98806452

Owner

ASPEYA SWITZERLAND SA

Attorney

Tamar Niv Bessinger

Filing Date

Oct 17, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ASPEYA Trademark

Serial Number: 98806452 • Registration: 8182964

ASPEYA is a trademark filed by ASPEYA SWITZERLAND SA on October 17, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 30 (Staple Foods), Class 32 (Light Beverages). The application is currently registered and active.

Owner Contact Info

ASPEYA SWITZERLAND SA (16 trademarks)

AVENUE DE RHODANIE 50
LAUSANNE 1007 , CH

Entity Type: 33

Vectura Fertin Pharma Switzerland S.A. (5 trademarks)

Avenue de Rhodanie 50
Lausanne 1007 , CH

Entity Type: 99

Trademark Details

Filing Date

October 17, 2024

Registration Date

March 24, 2026

Published for Opposition

February 3, 2026

Goods & Services

Medical research services; scientific research services in the field of smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical drug development services; research, and development of inhaled therapeutics; research, and development of pharmaceutical and well-being products for oral and intraoral delivery systems

mixes in the nature of syrups, powders, or concentrates for flavoring being preparation of non-alcoholic beverages being tea based beverages; non-alcoholic beverages, namely, tea

Medical devices for use for inhalation of pharmaceutical preparations, sold empty; medical devices sold empty for use for inhalation of aerosolized or inhaled therapeutics and pharmaceuticals; inhalers for therapeutic purposes, sold empty; dry powder inhalers (DPI) for therapeutic purposes, sold empty; nebulizer for medical purposes; pressurized metered dose inhalers (pMDI) for therapeutic purposes, sold empty

Non-alcoholic beverages, namely, flavored waters and mineral and aerated waters; Pastilles and powders for effervescing beverages, namely, effervescent tablets and powders for making sports drinks and soft drinks; Energy drinks; Isotonic beverages; Protein enriched sports beverages; Whey beverages; Syrups and other preparations for making non-alcoholic beverages, namely, concentrates, syrups, or powders used in the preparation of soft drinks, tea-flavored beverages, and fruit flavored beverages

Medical services; medical services in the area of inhaled therapeutics and pharmaceuticals and in the area of oral administration of pharmaceuticals

Pharmaceutical products, namely, smoking cessation preparations, analgesic preparations, sleep aid- preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties for the treatment mental health conditions, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical products for inhalation, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, antipyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties for the treatment of mental health conditions, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical products, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties for the treatment of mental health conditions, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders in chewable form, in gum form, in lozenge form, and in pouch powder form; nutraceuticals for the treatment of arthritis, preparations having psychotherapeutic properties for the treatment of mental health conditions, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; vitamins and dietary supplements; pharmaceutical preparations for inhalation for treatment of a wide variety of diseases and conditions being cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical preparations for treatment of a wide variety of diseases and conditions being cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders in chewable form, in gum form, in lozenge form, and in pouch powder form; nicotine chewing gum for use as an aid to stop smoking

Filing History

REGISTERED-PRINCIPAL REGISTER
Mar 24, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2026 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jan 9, 2026 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 30, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 30, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 30, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 30, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 30, 2025 CNEA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 1, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 1, 2025 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 2, 2025 GNFN
FINAL REFUSAL E-MAILED
Sep 2, 2025 GNFR
FINAL REFUSAL WRITTEN
Sep 2, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 5, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 5, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 5, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 5, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 5, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 5, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 28, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 27, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2025 NWOS
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 11, 2025 ASGN
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Dec 26, 2024 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 26, 2024 PARI
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Nov 20, 2024 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 20, 2024 PARI
NEW APPLICATION ENTERED
Oct 17, 2024 NWAP